Equine CEA antibody and antigen (recombinant protein)

Diagnostic anti-Equine CEA antibodies pairs and antigen for animal health (animal Equine/Horse breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-CEA-Ag01Equine CEA$3090.00
GMP-EQU-CEA-Ab01Anti-Equine CEA mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CEA-Ab02Anti-Equine CEA mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CEA-Ab03Anti-Equine CEA human monoclonal antibody (mAb)$3090.00
GMP-EQU-CEA-Ab04Anti-Equine CEA human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-CEA-Ag01
Product NameEquine CEA
Target/BiomarkerEquine CEA
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine CEA antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
TagHis
Reconized/Reactive SpecicsEquine CEA
Product descriptionRecombinant Equine CEA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CEA-Ab01,GMP-EQU-CEA-Ab02
Target/BiomarkerEquine CEA
Product NameAnti-Equine CEA mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine CEA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies in Equine CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
Product descriptionAnti-Equine CEA mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CEA-Ab03,GMP-EQU-CEA-Ab04
Target/BiomarkerEquine CEA
Product NameAnti-Equine CEA human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine CEA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies in Equine CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer.
Product descriptionAnti-Equine CEA mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Carcinoembryonic Antigen (CEA) in horses (equines) is a glycoprotein biomarker with important implications in various physiological and pathological processes. Structurally, CEA belongs to the immunoglobulin superfamily and features multiple immunoglobulin-like domains, enabling its role in cell adhesion processes and tissue development. While CEA is actively produced during fetal development, its presence in healthy adult horses is typically limited to very low levels.

    During fetal development, CEA is involved in cell adhesion, promoting the formation and integrity of various tissues. Its function is primarily to mediate interactions between cells, contributing to the organization and stability of tissues during embryonic growth.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.